share_log

EF Hutton Reiterates Buy on Bone Biologics, Maintains $2.25 Price Target

Benzinga ·  Apr 13, 2023 07:03

EF Hutton analyst Constantine Davides reiterates Bone Biologics (NASDAQ:BBLG) with a Buy and maintains $2.25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment